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Drosophila, like other insects, responds to the injection of bacteria by the raptd and transient synthesis of a battery of potent antibacterial peptides. 
Only a few of these peptides have been fully characterized to date. We review our recent data on the control of the expression of a gene encoding 
one of the induced peptides, i.e. diptericin. Our data highlight the role of proximal cis-regulatory motifs similar to regulatory elements binding 
NF-KB and NF-IL6 in promoters of some immune genes of mammals. We argue that the Drosophila host defense is homologous to the mammalian 
acute phase response. 
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1. INTRODUCTION 
Insects have long been known to be particularly resis- 
tant to bacteria. While early workers in the late 19th 
century attributed this resistance to phagocytosis and to 
encapsulation by hemocytes [1,2], several independent 
studies established around 1920 that insects could be 
protected against he injection of lethal doses of bacteria 
by previous administration of low doses [3-51. This in- 
duced protection was correlated to the appearance of a 
potent antibacterial activity in the cell-free hemolymph. 
The early studies, and most of the subsequent investiga- 
tions in the field of insect immunity, were performed on 
large-sized insect species. It was only in 1972 that the 
problem of the inducible antibacterial activity was di- 
rectly addressed in the small-sized Drosophila. Studies 
by Boman and associates [6] demonstrated that in 
Drosophila, like in other insect species, a primary infec- 
tion can induce a protection against a secndary infection 
which otherwise would be lethal. However, as Boman 
later put it, ‘the biochemistry behind this phenomenon 
could not be worked out at that time’ [7]. In spite of the 
obvious interest of Drosophila as a model system, 
Boman and associates turned to the large pupae of the 
Cecropia moth for the first successful isolation of in- 
duced antibacterial molecules (cecropins [8] and attac- 
ins [9]), while other groups worked on large-sized fly 
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species, like Sarcophaga peregrina (isolation of the ce- 
cropin-like sarcotoxins I [lo], the attacin-related sar- 
cotoxins II [l I] and sapecin, a homologue of insect 
defensin [I 21) or Phormiu terranovae (isolation of dipter- 
icins [13] and insect defensins [14]) (for reviews on these 
peptides, see e.g. [15-l 71). 
In the mid-eighties, two independent studies con- 
firmed that Drosophila, like other insects, responds to 
the inoculation of bacteria within a few hours by the de 
novo synthesis of several peptidic or polypeptidic mole- 
cules, some of which were presumed to be homologous 
of cecropins and attacins [7,18]. However, still at that 
time, the structures of the molecules remained elusive, 
as a consequence of the low amounts which could be 
extracted from these small-sized insects. 
2. THE INDUCIBLE ANTIBACTERIAL PEP- 
TIDES OF Drosophila 
The first information on the sequences of inducible 
antibacterial peptides of Drosophila was obtained from 
DNA cloning studies published in 1990. Using a cDNA 
clone corresponding to the major cecropin isolated by 
Natori’s group from Sarcophagu peregrina [lo], 
Hultmark and associates [ 19,201 were able to character- 
ize in the genome of Drosophila a compact cluster com- 
prising three expressed cecropin genes plus two pseu- 
dogenes. Two of these genes (A,, AZ) code for a cecropin 
with a deduced amino-acid sequence identical to the 
major cecropin of Sarcophaga peregrina. The other (B) 
of the three expressed genes codes for a cecropin which 
differs by five conservative amino-acid replacements. In 
association with Hultmark’s group, we isolated in 1990 
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CECROPIN AI /A2 : GWLKKIGKKI ERVGQHTRDA TIQGLGIAQQ AANVAATAR 
CECROPIN B : GWLRKLGKKI ERIGQHTRDA SIQVLGIAQQ AANVAATAR 
CECROPIN C : GWLKKLGKRI ERIGQHTRDA TIQGLGIAQQ AANVAATAR 
June 1993 
DIPTERICIN : DDMTMKPTPP PQYPLNLQGG GGGQSGDGFG FAVQGHQKVW 
TSDNGRHEIG LNGGYGQHLG GPYGNSEPSW KVGSTYTYRF PNF 
Fig. 1. Structures of inducible antibacterial peptides of Drosophila The amino-acid sequences of cecropins [19,20,23] and diptericin [21] were 
deduced from DNA cloning studies; cecropin A was directly isolated from immune adults of Drosophila in our laboratory and the deduced sequence 
[19] was confirmed by Edman degradation and molecular mass determination (m/z = 4155.2). Bold residues differ among the three expressed 
cecropins [19,20,23]. We suspect diptericin to be post translationally modified by 0-glycosylation, as demonstrated in the case of diptericin from 
the fleshfly Phormia terranovae (unpublished). 
a Drosophila cDNA encoding a novel member of the 
diptericin family of inducible antibacterial peptides [21]. 
We used an oligonucleotide probe corresponding to the 
peptide sequence of the newly-isolated diptericin from 
the fleshfly Phormia terranovae [22]. A fourth cecropin 
gene (C), encoding a peptide which differs from ce- 
cropin A by three conservative amino-acid replace- 
ments, was later described [23]. In essence, these studies 
established that Drosophila expresses, in response to 
bacterial challenge, genes encoding antibacterial pep- 
tides which are homologous to cecropins and dipter- 
icins, previously isolated from other insect species (Fig. 
1). 
Taking advantage of the recent refinements in the 
methods of analytical chemistry, we have started the 
direct isolation and characterization of the antibacterial 
peptides of immunized Drosophila. An exciting first re- 
sult was that a major inducible peptide is a novel 19- 
residue, proline-rich cationic peptide which carries a 
substitution which is mandatory for full biological ac- 
tivity of this molecule, which we have named drosocin 
[24]. Drosocin is active both against Gram-positive and 
Gram-negative bacteria. We have also identified a pep- 
tide corresponding to the sequence deduced by the 
Hultmark group from cecropin genes A, and A, (Fig. 
1) and a novel member of the family of insect defensins. 
The sequence of Drosophila defensin and that of its gene 
will be reported in detail elsewhere [25]. 
The isolation of other inducible immune peptides of 
Drosophila is in progress and to date we have character- 
ized half a dozen of novel cationic, small-sized (2 to 9 
kDa) antibacterial peptides (unpublished). Drosophila 
also produces larger-sized antibacterial polypeptides, 
according to the data of earlier studies [7,18], and we 
speculate that the total number of inducible anti- 
bacterial molecules is well in excess of a dozen. It is at 
present unclear why Drosophila would need such a large 
number of different antibacterial peptides for its protec- 
tion. A possibility is that the activity spectra of the 
various peptides are complementary and allow the in- 
sect to respond to a large variety of invaders. It may also 
be that some of these molecules synergize in a way 
which we still do not understand. 
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3. EXPRESSION OF THE IMMUNE GENES OF 
Drosophila 
Studies performed on the expression profiles of the 
genes encoding cecropins [19,20,23], diptericin [21], de- 
fensin [25] and drosocin [24] in bacteria-challenged 
Drosophila yielded results similar to those obtained in 
other species of the recent insect orders (namely in Hv- 
alophora cecropia (reviewed in [15]), Munduca sexta 
[26], Sarcophuga peregrina [ 11,27-291, Phormia terrano- 
vae [30]). The genes are rapidly transcribed following 
challenge (1 to 2 h), the transcription rate increases over 
a period varying between 6 and 24 h, depending on the 
gene, and thereafter either stops or levels off. Not all the 
genes are transcribed with the same intensity during the 
response; the induction of the drosocin gene for instance 
is considerably stronger than that of defensin in larvae 
and adults of Drosophila [24,25]. Some of the genes are 
preferentially transcribed in challenged pupae: this is 
the case for the cecropin B and C genes, for instance, 
whose induced transcriptional rate is negligible in larvae 
and adults when compared to that of the cecropin A, 
and A, genes [23]. Interestingly, the expression of some 
of these genes can occur in the absence of an apparent 
immune challenge: the defensin gene for instance is ex- 
pressed in normal early pupae [25] (cf. also [29] for 
Sarcophaga). The fat body, a functional equivalent of 
the mammalian liver, is a major site of transcription of 
the inducible antibacterial peptides; blood cells also par- 
ticipate in the production of these molecules and for 
some of the peptides, other tissues may be involved (e.g. 
pupal hindgut for cecropin C [23]; gut for defensin [25]). 
The humoral antibacterial response of Drosophila, 
like that of other insects, is strongly evocative of the 
acute phase response of mammals (reviewed in [3 11); in 
contrast it does not exhibit the hallmarks of the mam- 
malian lymphocyte response, i.e. specificity and mem- 
ory. The acute phase response is well preserved 
throughout phylogeny and plays important roles in the 
host defense against tissue damage and infection. In 
mammals, this response is induced by a variety of stim- 
uli such as bacterial infections or tissue injury and is 
characterized by significant alterations in the serum 
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Fig. 2. Promoter elements of the Drosophila diptericin gene. Distribution of sequences homologous to vertebrate immune gene response elements 
in the 2.2 kb diptericin promoter fragment. (i) Sequences related to mammalian NF-KB response element: (0) two 17-bp repeats harbouring a 
decameric rcB-related sequence 5’-GGGGATTCCT-3’; (0) a decameric rcB-related sequence 5’-GGGAAATTCC-3’; (ii) sequences related to 
mammalian NF-IL6 response lements: (m) NF-IL6 consensus 5’-TT/GNNGNAAT/G-3’; (0) IL6 RE-BP consensus 5’-CTGGGA-3’. Footprinting 
experiments have been recently performed [32] with a DNA fragment comprising the four most proximal binding motifs and have confirmed that 
they are actually protected against DNase I digestion by extracts of fat body from bacteria-challenged larvae (but not from control insects). The 
possible protection of the more upstream sequences has not yet been tested. 
level of several plasma proteins, known as acute phase 
proteins, many of which act as antiproteinases, opson- 
ins, blood-clotting and wound-healing factors. These 
proteins are mainly synthesized in the liver and to a 
lesser extent in extrahepatic cell types which include 
monocytes, tissue macrophages and fibroblasts. 
The coordinate expression of the acute phase protein 
genes in mammals is at present the focus of intense 
research. We are similarly interested in the analysis in 
Drosophila of the control of the expression of the anti- 
bacterial peptides, which mimics that of acute phase 
reactants. We have selected the diptericin gene as a 
model system. Drosophila contains one single, intron- 
less, gene encoding an 82-residue diptericin. The gene 
is rapidly induced in the fat body cells upon bacterial 
challenge [21]. To dissect he regulation of this gene, we 
have first transformed flies with a fusion gene in which 
the reporter /3-galactosidase gene is under the control of 
2.2 kb upstream sequences of the diptericin gene. We 
have shown that this fusion gene is inducible by injec- 
tion of bacteria and respects the tissue-specific expres- 
sion pattern of the resident gene [30]. To narrow down 
the functional analysis of potential c&regulatory ele- 
ments within this 2.2 kb fragment, we have next per- 
formed in vitro footprinting experiments on 300 bp of 
DNA immediately upstream of the TATA box [32]. 
Four distinct stretches of DNA were found to be pro- 
tected against DNase I digestion by protein extracts 
from fat body of bacteria-challenged Drosophila adults, 
but not from control insects (Fig. 2). The protected 
motifs are: (i) two 17-bp repeats harbouring a consensus 
motif for binding of NF-KB, a mammalian inducible 
transactivator involved in the control of expression of 
immune genes; NF-KB related motifs have been found 
in all genes encoding inducible antibacterial peptides in 
insects since the initial report of Faye and co-workers 
on their presence in the attacin gene promoter of Hyalo- 
phora cecropia [33]. In mammals, the function of NF-KB 
is to rapidly induce gene expression upon extracellular 
stimulations that signal distress and pathogen invasion 
(reviewed in [34]); in particular, NF-lcB controls the 
expression of acute phase proteins in the mammalian 
liver and KB motifs can serve as response elements for 
LPS; (ii) two consensus motifs for binding of NF-IL6; 
this protein is a member of the C/EBP family of induc- 
ible transactivating proteins and has been associated 
with acute phase regulation [35]. Sequences identical to 
the protected NF-IL6 consensus motifs of the diptericin 
promoter are also present in the genes coding for other 
inducible antibacterial peptides of insects. 
We are in the process of investigating the functional 
relevance of these motifs which are protected in induced 
tissues. So far we have analysed the role of the 17-bp 
repeats which harbour a FcB-related ecameric consen- 
sus sequence. We have demonstrated that the replace- 
ment of the two 17-bp repeats by random sequences 
abolishes bacteria inducibility in transgenic fly lines 
[36]. In association with E. Gateff we have shown that 
in a tumorous blood cell line [371, the diptericin gene can 
be induced by addition of lipopolysaccharide (see also 
[38]). We have transfected these cells with plasmids in 
which upstream sequences of the diptericin gene were 
fused to a chloramphenicol acetyl transferase gene and 
observed a marked induction of the fusion gene by LPS 
when the 17-bp repeats were present. The replacement 
of both or either of the 17-bp motifs reduced dramati- 
cally LPS inducibility, whereas multiple copies signifi- 
cantly increased the level of transcriptional activation 
by LPS challenge [36]. 
In keeping with the data of the footprinting analysis, 
a specific DNA-protein binding activity could be evi- 
denced when the 17-bp probe was incubated with cyto- 
plasmic and nuclear extracts of induced tumorous 
blood cells or fat body from bacteria-challenged larvae. 
No DNA-binding activity was observed in extracts of 
non-induced cells or fat body of unchallenged larvae 
nor gut of challenged larvae [36]. The characterization 
of the transactivating proteins mediating the immune 
response via the 17-bp repeats is in progress. Our pres- 
ent data lead us to propose that the NF-lcB/rel related 
morphogen dorsal is involved in the activation of the 
diptericin gene [32]. 
As already mentioned, during the past few years, the 
cis-acting response elements of several mammalian 
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acute phase genes have been identified. Sequence simi- 
larity among analogous elements has been recognized 
and several candidate transcription controlling factors 
for acute phase reactant genes have been identified. 
These factors were found to be related either to NF-KB 
or to CYEBP [35]. The observations that consensus bind- 
ing motifs for members of these two families are present 
in the immune genes of insects and that they are pro- 
tected in induced tissues of Drosophila, as well as our 
experimental demonstration that FcB-related motifs play 
a pivotal role in the induction of the diptericin gene in 
this species, lend strong credibility to the proposal that 
the insect host defense is homologous to the mammalian 
acute phase response. 
An essential question which we have not yet ad- 
dressed is the following: how is this rapid non-adaptive 
response initiated in Drosophila. Although, to our 
knowledge, few structural data are available on immune 
response receptors of Drosophila [39], an increasing 
amount of information from other arthropod species 
points to the existence of non-clonally distributed recep- 
tors for common constituents of pathogenic microor- 
ganisms, such as LPS [40,41], mannans, peptidoglycans 
[42]. The binding of such conserved microbial constitu- 
ents by evolutionary primitive receptors (which are con- 
served in present-day mammals) certainly represents a 
major recognition event which elicits the immune re- 
sponse in Drosophila. 
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